Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics

Area of Science:

• Immunology
• Infectious Diseases
• Pharmacology

Background:

• Sepsis, a life-threatening organ dysfunction from infection, involves immune system dysregulation.
• Key pathological features include complement system overactivation and T-cell dysfunction.
• Current therapeutic interventions and diagnostic tests for sepsis remain insufficient.

Purpose of the Study:

• To explore combinational drug therapy for sepsis.
• To investigate the use of biologics and mathematical modeling in sepsis treatment.
• To identify potential repurposed complement and immune checkpoint inhibitors for sepsis.

Main Methods:

• Review of current literature on sepsis pathophysiology and treatment strategies.
• Analysis of emerging biologics targeting innate and adaptive immunity.
• Consideration of mathematical modeling for predicting patient responses to therapy.

Main Results:

• Combinational therapy, rather than monotherapy, is essential for managing sepsis complexity.
• Targeting complement and immune checkpoints offers novel therapeutic avenues.
• Predictive systems models can guide personalized combination therapies.

Conclusions:

• Precision medicine approaches using combination therapies are crucial for effective sepsis treatment.
• Mathematical modeling can personalize sepsis treatment by predicting individual patient responses.
• Repurposing complement and immune checkpoint inhibitors shows potential for sepsis management.